Press releases
-
ICON Reports Third Quarter 2022 Results
Quarter 3 revenue of $1,942.4 million representing an increase of 3.9% on prior year adjusted revenue and 7.4% on a constant currency organic basis. -
ICON selected by BARDA to conduct anthrax vaccine clinical trial
ICON plc announces that it has been selected by BARDA, part of the ASPR, in the Department of HHS, to execute an anthrax vaccine clinical trial.
-
ICON plc schedules third quarter 2022 earnings conference call
ICON plc schedules second quarter 2022 earnings conference call on Wednesday, November 2, 2022. -
ICON releases its 2021 ESG report
ICON plc today (6 Sept, 2022) releases its 2021 Environmental, Social and Governance (ESG) Report. -
ICON plc to Present at the 2022 Wells Fargo Healthcare Conference
ICON plc announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. The presentation will be webcast live from 10:25am EDT. -
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
ICON plc today announced that all resolutions at the Annual General Meeting of the Company (AGM) held on July 26, 2022 (which resolutions had all been recommended by the Board) were all duly passed by shareholders. -
ICON Reports Second Quarter 2022 Results
Quarter 2 revenue of $1,935.2 million representing a year on year increase of 122.1%. -
ICON establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses
ICON establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses. -
ICON plc schedules second quarter 2022 earnings conference call
ICON plc schedules second quarter 2022 earnings conference call on Wednesday, July 27, 2022 -
ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference
Tuesday, May 24, 2022, at 7:00am ET.
